Home Newsfeeds Apple To Implement Scheduling Changes For All U.S. And Canada Retail Employees

Apple To Implement Scheduling Changes For All U.S. And Canada Retail Employees

-Bloomberg https://www.bloomberg.com/news/newsletters/2023-02-26/apple-aapl-exploratory-design-group-xdg-no-prick-glucose-tracker

byCharles Gross

February 26, 2023

1 minute read

-Bloomberg

https://www.bloomberg.com/news/newsletters/2023-02-26/apple-aapl-exploratory-design-group-xdg-no-prick-glucose-tracker

Here’s How Much You Would Have Made Owning Cadence Design Sys Stock In The Last 5 Years

By Benzinga Insights

May 16, 12:30 PM

Cadence Design Sys (NASDAQ:CDNS) has outperformed the market over the past 5 years by 21.71% on an annualized…

CDNS

US Senate Grills UnitedHealth CEO Over Cyberattack Fallout, Ransom Payment

By Vandana Singh

May 1, 3:52 PM

UnitedHealth Group's CEO addresses Senate concerns over cybersecurity risks, reassuring stability amid recent challenges. Learn more about the implications for healthcare and the economy.

UNH

Dan Niles Expects ‘Beat And Raise Quarters’ From Nvidia, Google, But He’s Short Apple, Tesla: Here’s Why

By Adam Eckert

October 10, 4:38 PM

Satori Fund founder and portfolio manager Dan Niles is long two mega-cap tech stocks into earnings and short another two.

AAPL

Apellis Pharmaceuticals Q2 EPS $(1.46) Misses $(1.36) Estimate, Sales $16.32M Miss $16.94M Estimate

By Bill Haddad

August 8, 4:45 PM

Apellis Pharmaceuticals (NASDAQ:APLS) reported quarterly losses of $(1.46) per share which missed the analyst consensus estimate of $(1.36) by 7.35 percent. This is a 46.32 percent increase over losses of $(2.72) per

APLS

Apple To Implement Scheduling Changes For All U.S. And Canada Retail Employees

Related Posts

Here’s How Much You Would Have Made Owning Cadence Design Sys Stock In The Last 5 Years

US Senate Grills UnitedHealth CEO Over Cyberattack Fallout, Ransom Payment

Dan Niles Expects ‘Beat And Raise Quarters’ From Nvidia, Google, But He’s Short Apple, Tesla: Here’s Why

Apellis Pharmaceuticals Q2 EPS $(1.46) Misses $(1.36) Estimate, Sales $16.32M Miss $16.94M Estimate